Equity Details
Price & Market Data
Price: $1.03
Daily Change: -$0.02 / 1.94%
Daily Range: $1.01 - $1.06
Market Cap: $3,880,835
Daily Volume: 22,442
Performance Metrics
1 Week: -4.67%
1 Month: 13.46%
3 Months: -46.88%
6 Months: -57.14%
1 Year: -80.19%
YTD: -43.96%
About Alzamend Neuro, Inc. (ALZN)
Summarized market data for Alzamend Neuro, Inc. (ALZN). Price: 1.03, daily change: -$0.02 / 1.94%. Market cap: 3,880,835. Performance over 3-month and 6-month periods.
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.